Beltway Confidential

Sen. Rand Paul leads first hearing on ‘dangerous’ gain-of-function research

By Christopher Tremoglie
Published August 4, 2022 5:43pm ET
Add Washington Examiner on Google
Sen. Rand Paul leads first hearing on ‘dangerous’ gain-of-function research
Rand Paul revealed a replacement for Obamacare that would have a bigger impact on employer-sponsored plans than other Republican alternatives. (AP Photo/Timothy D. Easley) | Timothy D. Easley

Sen. Rand Paul (R-KY) led the Senate’s first hearing on Wednesday to determine whether U.S. taxpayer-funded gain-of-function research contributed to the spread of COVID-19. The hearing was held by the Senate Homeland Security and Governmental Affairs Subcommittee on Emerging Threats and Spending Oversight. Not one Democrat attended.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

Commentary COVID-19 Rand Paul